Valve-in-Valve TAVR versus Redo Surgical Aortic Valve Replacement: Early Outcomes
Conclusion ViV-TAVR can be a safe and feasible alternative treatment option in patients with degenerated aortic valve bioprosthesis. The choice of treatment should include the patient's individual characteristics considering ViV-TAVR as a standard of care. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | open access Full text
Source: The Thoracic and Cardiovascular Surgeon - Category: Cardiovascular & Thoracic Surgery Authors: Cizmic, Amila Kuhn, Elmar Eghbalzadeh, Kaveh Weber, Carolyn Rahmanian, Parwis Baradaran Adam, Matti Mauri, Victor Rudolph, Tanja Baldus, Stephan Wahlers, Thorsten Tags: Original Cardiovascular Source Type: research
More News: Atrial Fibrillation | Blood Transusion | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Diabetes | Diabetes Mellitus | Endocarditis | Endocrinology | Heart | Heart Valve Surgery | Hypertension | Intensive Care | Study